Dov Shamir is the co-president of the NYU Biotechnology Association and is a PhD candidate in the Neuroscience and Physiology program at NYU's School of Medicine.  Dov is doing his thesis work in Dr. Einar Sigurdsson's Laboratory where he is studying the mechanisms of tau immunotherapies for Alzheimer's disease and other tauopathies.  Since rebooting NYUBA in Spring 2012 Dov has focused on garnering an entrepreneur/innovative atmosphere within the university by integrating NYUBA initiatives with the NYU Entrepreneur Institute, NYC Tech Connect, and other city wide run organizations.
